Neupath Health Inc. (TSE:NPTH) has released an update.
NeuPath Health Inc. has demonstrated financial growth with its second-quarter revenue reaching $18.9 million, an 11% increase from the previous year, and a 22nd consecutive quarter of positive adjusted EBITDA at $1.3 million. The company also reported a significant reduction in net debt by 37%, indicating stronger cash flows and financial stability.
For further insights into TSE:NPTH stock, check out TipRanks’ Stock Analysis page.
